Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
NetraMark Positioned to Advance Psychedelic Clinical Trials Following U.S. Executive Order, Supported by Peer-Reviewed Research and Active Programs
-
Allpoints Services Names Longtime Homebuilding Executive John Ballard as CRO
-
Ligand to Report First Quarter 2026 Financial Results on May 7, 2026
-
BeyondSpring Reports Compelling New Data: Plinabulin Advances Both the Anticancer Efficacy and Safety of ADC Drugs
-
Geron Plans to Announce First Quarter 2026 Financial Results on May 6, 2026
-
Sironax Announces Abstract on SARM1 Inhibitor SIR2501 Selected for Presentation at 2026 ASCO Annual Meeting
-
Fidelity D & D Bancorp, Inc. Reports First Quarter 2026 Financial Results
-
Edenor Informs the Market that on April 14th, 2026, it has Filed its Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2025.
-
"Three Corners of Deception 2" Movie In the Making Announced
-
DMH Asphalt Denver Explains Why Summer Is the Most Critical Season for Commercial Pavement Maintenance in Colorado
-
Gensyn Launches Delphi, the AI-Powered Information Market Reshaping the $250 Billion Creator Economy
-
Hamilton Lane Launches Two Interval Funds Across Private Credit and Private Infrastructure, Leveraging Extensive Expertise and Deep Track Records
-
Dr. Electric Explains What Colorado Springs Homeowners Should Check Before Summer Electrical Demand Peaks
-
Ms. and Mr. Health & Fitness 2026 Champions Crowned, Competition Raises Nearly $5 Million to Support B+ Foundation
-
Labcorp Launches FDA-Approved Companion Diagnostic to Identify Patients with Ovarian Cancer Eligible for KEYTRUDA®
-
Spinnaker Insurance Company Achieves AM Best Financial Size Category IX
-
SEED Therapeutics Reports Tumor Eradication in a Neuroblastoma In Vivo Model with Clinical-Stage RBM39 Molecular Glue Degrader ST-01156
-
Positive Clinical Data on Biomarkers in Patients Receiving Reqorsa® Gene Therapy To Be Released at the 2026 ASCO Annual Meeting
-
Lantronix to Report Fiscal 2026 Third Quarter Results on May 6, 2026
-
MCA Aviation Joins The Blackhawk Group to Expand Blackhawk's Performance Center Network to European Operators
-
AerCap Publishes Corporate Responsibility Report for 2025
-
Jade Biosciences Appoints Edward R. Conner, M.D., as Chief Medical Officer
-
NovaBridge Appoints Mark Hagler as President and Chief Commercial Officer to Advance Commercial Strategy and Maximize Pipeline Value
-
Take Profit Trader deploys Eventus Validus platform for trade surveillance of 90,000+ active traders
-
EvolveImmune Therapeutics Highlights Progress for Lead Asset EVOLVE104 and EVOLVE T Cell Engager Platform in Multiple Presentations at 2026 AACR Annual Meeting
-
Shapiro+Raj Launches an AI Agent Built Specifically for the Life Sciences Industry, Appoints Scott Swigart and Amir Kapadia to Lead Its Growth
-
Picard Medical / SynCardia Reports Revenue Growth Based on Top-line Results for the First Quarter 2026
-
Actinium Highlights Transcriptional Reprogramming as a Key Mechanism Underpinning Mutation-Agnostic Activity of Actimab-A in AML at the 2026 American Association of Cancer Research Annual Meeting
-
Actinium Pharmaceuticals, Inc. Announces Compelling Pan-Tumor Data for ATNM-400 Demonstrating Broad Efficacy Across Prostate, Lung, and Breast Cancer Models at the 2026 American Association of Cancer
-
Spire announces sale of its Mississippi natural gas business to Delta Utilities for $75 million
-
SiriusXM Media Becomes Exclusive Audio Advertising Representative for YouTube in the United States
-
Behrman Capital Acquires Metallizing Service Company
-
Blockchain Pioneer Barry Mezey Elevates Autism Advocacy in Season Two of Hit Reality Series Crypto Knights
-
AvevoRx Expands Specialty Infusion Pharmacy Network With New Clean-Room Facility in Austin, Texas
-
Strayer University Student Team Wins NSA Codebreaker Challenge
-
Precision BioSciences Announces Late-Breaking Poster Presentation for PBGENE-HBV at European Association for the Study of the Liver Congress 2026
-
Norck Introduces Network-Driven U.S. Manufacturing Model to Eliminate Supply Chain Bottlenecks and Accelerate High-Precision Production
-
Stifel Reports First Quarter 2026 Results
-
Advantage Solutions Announces Date for its First Quarter 2026 Financial Results and Conference Call
-
Rogers Communications Reports First Quarter 2026 Results
-
Aurora Mobile's EngageLab Redefines AI-Native Customer Engagement at NexTech Week Tokyo Spring 2026
-
Nurix Therapeutics Announces New Preclinical Data Highlighting Breadth of Targeted Protein Degradation Pipeline at AACR 2026
-
Certara Enters Definitive Agreement for the Sale of its Regulatory and Medical Writing Business to Veristat
-
Sweet Harvest Foods and Nate’s Hives Awarded Three Recipients of the Inaugural Nate’s Hives Research Grant Program
-
SAB BIO Presents Additional Clinical and Mechanistic Data from SAB-142 Phase 1 Trial in Adult Patients with Established Autoimmune Type 1 Diabetes at IDS 2026
-
NeurAxis Expands Payer Coverage with Four New Medical Policies
-
Old National Bancorp Reports First Quarter 2026 Results
-
Rafael Holdings Announces Patent Licensing Agreement with MIT for “Small Molecules to Improve Myelination in ApoE4 positive Alzheimer’s Disease”
-
BlossomHill Therapeutics Presents First Preclinical Data from New Pan-KRAS Inhibitor Program Built on a Novel Chemical Scaffold During Mini Symposium at AACR 2026
-
Nutriband CEO, Gareth Sheridan Discusses the US Fentanyl Crisis and Company Update on Latest Episode of the Jack Neel Podcast

